127 results
8-K
EX-99.1
DVAX
Dynavax Technologies Corp.
8 Jan 24
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
9:05am
, and tolerability of the plague vaccine candidate in 2024.
J.P. Morgan Healthcare Conference Presentation Webcast Details
Dynavax will present … at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11 at 11:15 a.m. PT.
The presentation will be webcast and may be accessed through
8-K
EX-99.2
DVAX
Dynavax Technologies Corp.
8 Jan 24
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
9:05am
Developing and Commercializing Innovative Vaccines 42nd Annual J.P. Morgan Healthcare Conference January 2024 Nasdaq: DVAX
Forward-Looking
8-K
EX-99.1
n01gxgj wpq
2 May 23
Dynavax Reports First Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
319gq6ha
5 May 22
Dynavax Reports First Quarter 2022 Financial Results
4:04pm